Ovarian Cancer: Options and Risks1 - Options:Patients are categorized as a patient

Cancer Patient Quality Of LifeThe concept of quality of life has been critically

More than 30 years of research underlie the approaches that we now use in a standard

LYNPARZA is the only PARP inhibitor approved for the 4 types of advanced

Okay, so I’ve got a patient with advanced ovarian cancer. What are the options

LYNPARZA is the only PARP inhibitor approved for the following 4 types of advanced

So it's actually been a very exciting time in the last couple of years. For

PARP inhibitors have a significant role to play in the treatment and management

As our population grows and grows older. So the number of cancer sufferers will

Ketogenic nutrition support terminology  either parenteral nutrition or enteral